Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, is not a dichotomous
disease trait. Technological innovations enable long-term rhythm monitoring in many …

Atrial fibrillation (AF) may be asymptomatic and the extensive monitoring capabilities of
cardiac implantable electronic devices (CIEDs) revealed asymptomatic atrial tachi …

Abstract Background ARTESiA (Apixaban for the Reduction of Thrombo-Embolism in
Patients With Device-Detected Sub-Clinical Atrial Fibrillation) demonstrated that apixaban …

Background Short and rare episodes of atrial fibrillation (AF) are commonly detected using
implanted devices (device‐detected AF) in patients with prior stroke or transient ischemic …

Automated continuous rhythm monitoring has been made possible with the extensive use of
cardiac implantable electronic devices (CIEDs). A highly prevalent finding in devices with …

Aims Recent trial data demonstrate beneficial effects of active rhythm management in
patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is …

Atrial fibrillation is one of the most common cardiac arrhythmias and is a major cause of
ischaemic stroke. Recent findings indicate the importance of atrial fibrillation burden (device …

Atrial fibrillation (AF) is an arrhythmia that affects the left atrium, cardiac function, and the
patients' survival rate. Due to empowered diagnostics, it has become increasingly …

One in six ischaemic stroke patients has an embolic stroke of undetermined source (ESUS),
defined as a stroke with unclear aetiology despite recommended diagnostic evaluation. The …

Availability of devices capable of continuous rhythm monitoring such as smartwatches,
implantable loop recorders, or pacemakers/defibrillators is continuously increasing …